JP2009520791A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009520791A5 JP2009520791A5 JP2008546614A JP2008546614A JP2009520791A5 JP 2009520791 A5 JP2009520791 A5 JP 2009520791A5 JP 2008546614 A JP2008546614 A JP 2008546614A JP 2008546614 A JP2008546614 A JP 2008546614A JP 2009520791 A5 JP2009520791 A5 JP 2009520791A5
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen
- compound
- ring
- methyl
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0526169.8 | 2005-12-22 | ||
| GB0526169A GB0526169D0 (en) | 2005-12-22 | 2005-12-22 | Enzyme inhibitors |
| GB0620884A GB0620884D0 (en) | 2006-10-20 | 2006-10-20 | Enzyme inhibitors |
| GB0620884.7 | 2006-10-20 | ||
| PCT/GB2006/004854 WO2007072017A2 (en) | 2005-12-22 | 2006-12-21 | Enzyme inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009520791A JP2009520791A (ja) | 2009-05-28 |
| JP2009520791A5 true JP2009520791A5 (https=) | 2010-02-12 |
| JP5205276B2 JP5205276B2 (ja) | 2013-06-05 |
Family
ID=38091678
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008546614A Active JP5205276B2 (ja) | 2005-12-22 | 2006-12-21 | 酵素阻害剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8088761B2 (https=) |
| EP (1) | EP1963315B1 (https=) |
| JP (1) | JP5205276B2 (https=) |
| ES (1) | ES2526813T3 (https=) |
| WO (1) | WO2007072017A2 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008121064A1 (en) * | 2007-03-30 | 2008-10-09 | Astrazeneca Ab | New imidazo[4,5-b]pyridine-6-halo-7-aryl/heteroaryl compounds 705 |
| WO2009001021A1 (en) * | 2007-06-26 | 2008-12-31 | Chroma Therapeutics Ltd. | Imidazopyridine derivatives useful as enzyme inhibitors for the treatment of cell proliferative and autoimmune diseases |
| US8987307B2 (en) | 2011-03-03 | 2015-03-24 | Hoffmann-La Roche Inc. | 3-amino-pyridines as GPBAR1 agonists |
| ES2567552T3 (es) * | 2012-01-30 | 2016-04-25 | Cephalon, Inc. | Imidazo [4,5-b] derivados de piridina como los moduladores ALK y JAK para el tratamiento de trastornos proliferativos |
| AR090789A1 (es) * | 2012-04-23 | 2014-12-10 | Genentech Inc | Intermediarios y procesos para la preparacion de compuestos |
| GB201211021D0 (en) * | 2012-06-21 | 2012-08-01 | Cancer Rec Tech Ltd | Pharmaceutically active compounds |
| GB201211019D0 (en) * | 2012-06-21 | 2012-08-01 | Cancer Rec Tech Ltd | Inhibitor compounds |
| CA2890288A1 (en) * | 2012-11-16 | 2014-05-22 | Merck Patent Gmbh | Novel heterocyclic derivatives as modulators of kinase activity |
| UY36390A (es) * | 2014-11-05 | 2016-06-01 | Flexus Biosciences Inc | Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen |
| MX2017005462A (es) | 2014-11-05 | 2017-07-28 | Flexus Biosciences Inc | Agentes inmunorreguladores. |
| EP3253754B1 (en) | 2015-02-02 | 2021-03-31 | Kancera AB | 2-phenyl-3h-imidazo[4,5-b]pyridine derivates useful as inhibitors of mammalian tyrosine kinase ror1 activity |
| CN109563092B (zh) | 2016-07-11 | 2021-09-14 | 坎塞拉有限公司 | 可用作哺乳动物酪氨酸激酶ror1活性的抑制剂的2-苯基咪唑并[4,5-b]吡啶-7-胺衍生物 |
| US11660303B2 (en) | 2016-07-11 | 2023-05-30 | Kancera Ab | 2-phenylimidazo[4,5-b]pyridin-7-amine derivates useful as inhibitors of mammalian tyrosine kinase ROR1 activity |
| CN112239465A (zh) | 2019-07-16 | 2021-01-19 | 微境生物医药科技(上海)有限公司 | 极光激酶抑制剂及其用途 |
| AR129965A1 (es) * | 2022-07-20 | 2024-10-16 | Sanofi Sa | Compuestos de imidazopiridina, preparación de los mismos y usos terapéuticos de los mismos |
| WO2026020051A1 (en) * | 2024-07-19 | 2026-01-22 | Nurix Therapeutics, Inc. | Bifunctional compounds for degrading aurora kinase via ubiquitin proteosome pathway |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ID24300A (id) * | 1997-08-05 | 2000-07-13 | Pfizer Prod Inc | 4-AMINOPIROL(3,2-d)PIRIMIDIN SEBAGAI ANTAGONIS-ANTAGONIS RESEPTOR NEUROPEPTIDA Y |
| JP2004503553A (ja) * | 2000-06-14 | 2004-02-05 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | ６，５−縮合二環式複素環 |
| SE0202462D0 (sv) * | 2002-08-14 | 2002-08-14 | Astrazeneca Ab | Novel use |
| US7534796B2 (en) | 2005-02-18 | 2009-05-19 | Wyeth | Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor |
-
2006
- 2006-12-21 EP EP06820620.0A patent/EP1963315B1/en active Active
- 2006-12-21 WO PCT/GB2006/004854 patent/WO2007072017A2/en not_active Ceased
- 2006-12-21 JP JP2008546614A patent/JP5205276B2/ja active Active
- 2006-12-21 US US12/158,339 patent/US8088761B2/en active Active
- 2006-12-21 ES ES06820620.0T patent/ES2526813T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009520791A5 (https=) | ||
| JP2016513660A5 (https=) | ||
| JP2010506825A5 (https=) | ||
| JP2011513305A5 (https=) | ||
| JP2010538076A5 (https=) | ||
| JP2018522823A5 (https=) | ||
| JP2016503786A5 (https=) | ||
| JP2015503529A5 (https=) | ||
| JP2012510989A5 (https=) | ||
| NZ593594A (en) | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | |
| JP2016535000A5 (https=) | ||
| RU2004135066A (ru) | Ингибиторы деацетилазы гистонов | |
| JP2013545791A5 (https=) | ||
| JP2002520309A5 (https=) | ||
| JP2009533410A5 (https=) | ||
| JP2014508811A5 (https=) | ||
| JP2007519735A5 (https=) | ||
| JP2007518682A5 (https=) | ||
| JP2005507918A5 (https=) | ||
| JP2016501250A5 (https=) | ||
| JP2013544854A5 (https=) | ||
| JP2016534124A5 (https=) | ||
| JP2007231005A5 (https=) | ||
| JP2005518357A5 (https=) | ||
| JP2010527984A5 (https=) |